Thanks, Justice Kavanaugh!

The drop in confidence comes as the Supreme Court debates the future of the abortion pill.

As the nation awaits a final decision on the abortion pill, amid dueling legal cases, there is one easy way the FDA could help make sure people still have access.

On abortion medication, the justices would have very good reasons to leave the status quo intact for FDA drug approvals.

Abortion was all Republicans would talk about before. Their silence now speaks volumes.

The proposed rule change is a big shift in blood donation guidelines, but it still doesn’t go far enough.

These are two of the biggest pharmacy chains in the country.

We pay more attention when influencers are hospitalized after something they ate. But foodborne illness is incredibly common in the United States. Why is that?

There’s nothing the president can do to stop the Supreme Court from ending the right to abortion. But some legal experts and pro-choice activists have proposed creative ways to limit the damage.

Most members of the Congressional Black Caucus agree that the ban is a great move. So why is Al Sharpton taking the side of R.J. Reynolds?

Experts want to know why the agency approved a questionable Alzheimer’s drug but has withheld full approval from Covid vaccines.

A prolific seller of “all-natural” sexual enhancement pills was shut down by the FDA. So why can you still buy Stiff Nights all over the place?

Has our collective concern over teen vaping led us to ignore the lives of millions and millions of smokers?

The CDC and FDA got a black eye in 2020. Here’s how they can earn back the public’s trust.

The emergency use authorization will make plasma and immunology research much harder—not ideal during a pandemic.

After bungling containment, the Trump administration hopes for a fast-tracked fix. But compressing trials comes with its own hazards.

BioCorRx facilitated an anti-opioid implantation in an incarcerated person earlier this year. But the procedure hadn’t been approved by the FDA.

A new book explores the tangled politics behind a global addiction.

The FDA's new proposal stirs up an old, complicated debate.